3 April: Discriminatory COVID-19 triage decisions unacceptable

Alzheimer Europe and its members have launched a call to governments and health systems to urgently increase the infrastructure for intensive care needed for people affected by COVID-19, and to ensure regulations around access to life-saving treatment are based on sound ethical principles.

Read more »
Rate: 12345 (0) | Facebook Twitter
9 April: Iceland launches National Dementia Strategy

Iceland’s Ministry of Health has published a national strategy on dementia setting out a plan for services for people with dementia until 2025. The plan covers six areas and defines 48 actions, each with specific measurable goals. Some measures have already been implemented.

Read more »
Rate: 12345 (0) | Facebook Twitter
14 April: AE Board adopts COVID-19 wellbeing recommendations

The Alzheimer Europe Board has adopted recommendations for Alzheimer associations, health and social care professionals on how to promote the wellbeing of people with dementia and carers during the COVID-19 pandemic.

Read more »
Rate: 12345 (0) | Facebook Twitter
22 April: Biogen aims to complete aducanumab FDA filing in Q3

Biogen has announced that it expects to complete the filing for its Alzheimer’s disease drug aducanumab, in the third quarter of this year.

Read more »
Rate: 12345 (0) | Facebook Twitter